Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. - Wikidata - wikimedia - TriplyDB

Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.

Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.

http://www.wikidata.org/entity/Q36785948

about

An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins.New para-para stilbenophanes: synthesis by McMurry coupling, conformational analysis and inhibition of tubulin polymerisation.The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics Antivascular actions of microtubule-binding drugs.Characterization of cervical lymph nodes using DCE-MRI: Differentiation between metastases from SCC of head and neck and benign lymph nodes.Vascular disrupting effect of CKD-516: preclinical study using DCE-MRI.Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.

P2860

Q33823154-84FA6C9A-8A84-4F04-AEFA-E6231C0D61D1 Q33827457-AA6FFB8C-E94D-4F0B-B250-0D3C7373BAF9 Q34122191-01E468EB-329C-426A-B332-2F0A0A7BFF08 Q34478450-B1528ADB-1672-46F7-B95D-712AE52B9A3C Q34538659-2B391FAE-0F4D-4956-8F5C-8A90C63522E2 Q35626527-E3CEBE6B-61E5-4A41-9385-9B34B7413B7F Q37349697-54C563CF-8268-4FAF-9A7A-48C57598A6EB Q40720743-AE30A3C5-E71F-4250-A757-8FA2CABCDD14 Q43792334-C0B0C045-1A1C-4056-A228-5B257DA0AD75 Q44255938-287D9A5F-3805-4729-B6AC-8D16D8675E29

P2860

Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.

http://www.wikidata.org/entity/Q36785948

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Relationship between human tum ...... hutdown: an exploratory study.

@en

type

label

Relationship between human tum ...... hutdown: an exploratory study.

@en

prefLabel

Relationship between human tum ...... hutdown: an exploratory study.

@en

P1433

Q36785948-7ABF1692-D052-4B5F-B90B-8A0111DC3495

P1476

Q36785948-8154742C-11B1-4391-B8AE-9259138A6AD2

P2093

Q36785948-29CFDC03-9858-42C5-95FE-EB1CCA013177

Q36785948-64FCC9E3-FB05-472D-8B83-E09B096AB664

Q36785948-7AD30FEC-4A36-4488-B640-8CE1646256A6

Q36785948-7CCFB409-3BAD-4839-A8D7-26CD8C9418EF

Q36785948-819D2B71-15A3-46FA-96A4-72295CFFC235

Q36785948-8B8196BF-FAFD-4AA7-B295-F3878AC0E417

Q36785948-8F845327-3F34-4461-8A70-1EAC95EA4ECB

Q36785948-A0952683-90D5-4F0D-B384-EE101A9AA683

Q36785948-E392A814-B71D-4296-8947-36CCC03F68F2

Q36785948-E59E0095-498D-48AE-8122-F702E1D61442

P2860

Q36785948-05BFFBF2-6428-4B1B-B53E-15BB8BD5FDC9

Q36785948-063D4685-E8B4-4DF2-84D6-9914752C5D19

Q36785948-06885EBA-B65A-4EBA-B35B-55190EFD705C

Q36785948-06E63424-7644-406A-97DA-C5544A8303B4

Q36785948-2220D6AB-D5F0-454E-9F00-B461CE8C32D8

Q36785948-22E216A3-E7E6-4E9C-84D7-C0DC95CE1585

Q36785948-2EF399ED-D355-4684-BB5D-B140D723A583

Q36785948-3043AB8A-7DE5-4039-B74A-40189BFD93F3

Q36785948-4204CB38-3F7B-4911-B3E2-7DE82889A043

Q36785948-50D83043-1F27-4EA2-8B77-98877EB1C1F3

P2888

Q36785948-4A22DEB6-19C1-4525-B5AC-6517BB776544

P304

Q36785948-00CA7CAB-E8A2-4AB9-A828-2BBE41F5A443

P31

Q36785948-01BCA434-D179-4107-AB5D-A85B7CB4F870

P356

Q36785948-AC40599D-5D67-4262-9FB6-ADB929069DE2

P407

Q36785948-7D1F0A8D-9EAC-499B-AD8D-D5B856707089

P433

Q36785948-6CC5CFBA-FA0F-4CF9-90E7-3CF5AAB8518C

P478

Q36785948-39CA07EF-DAFF-442C-A943-216A5D937679

P50

Q36785948-6D869BBA-1441-4CC9-972B-9490ADD58DAC

P577

Q36785948-DB50C700-D1EE-415A-A0B7-9DF2C07C31E6

P5875

Q36785948-65322502-E3F1-4CFE-853C-E04AEDCE4139

P698

Q36785948-889CAC65-D8FA-40B4-BD72-80FB0DF24071

P932

Q36785948-DFE5F857-F705-478C-AD7D-AD64C76AC9A8

P356

P1433

British Journal of Cancer

P1476

Relationship between human tum ...... shutdown: an exploratory study

@en

P2093

A Gaya

http://www.w3.org/2001/XMLSchema#string

A Padhani

http://www.w3.org/2001/XMLSchema#string

F Daley

http://www.w3.org/2001/XMLSchema#string

G Rustin

http://www.w3.org/2001/XMLSchema#string

G Tozer

http://www.w3.org/2001/XMLSchema#string

J J Stirling

http://www.w3.org/2001/XMLSchema#string

N J Taylor

http://www.w3.org/2001/XMLSchema#string

R B Pedley

http://www.w3.org/2001/XMLSchema#string

R Begent

http://www.w3.org/2001/XMLSchema#string

U Qureshi

http://www.w3.org/2001/XMLSchema#string

P2860

The enigmatic role of angiopoietin-1 in tumor angiogenesis

Key factors in the acquisition of contrast kinetic data for oncology.

Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data.

Angiopoietins in malignancy.

Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Microvessel density is a prognostic marker of human gastric cancer.

Angiogenic switch as a molecular target of malignant tumors.

Disrupting tumour blood vessels.

P2888

P304

321-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604426

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5239130

http://www.w3.org/2001/XMLSchema#string

P698

18612312

http://www.w3.org/2001/XMLSchema#string

P932

2480970

http://www.w3.org/2001/XMLSchema#string